Edwards Lifesciences target price raised to $118 from $113 by Truist Securities
EW•Truist Securities raised its target price on Edwards Lifesciences to $118 from $113.
Related News
FIS: RBC cuts to sector perform from outperform, lowers target price to $37 from $53
FIS•
Leishen Energy exhibits at ADIPEC 2026 for second consecutive year
LSE•
3D Systems to issue $85 million in convertible notes in debt exchange
DDD•
Piper Sandler raises Community Healthcare Trust Inc target price to $16 from $14
CHCT•
McDonald's: RBC raises target price to $300 from $285
MCD•